VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
42 hedge funds and large institutions have $10.1M invested in Viracta Therapeutics, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
28% less capital invested
Capital invested by funds: $14.1M → $10.1M (-$3.97M)
Holders
42
Holding in Top 10
1
Calls
$1K
Puts
–
Top Buyers
| 1 | +$93.7K | |
| 2 | +$29.4K | |
| 3 | +$13.9K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$12.6K |
| 5 |
UBV
United Bank (Virginia)
Vienna,
Virginia
|
+$10.2K |
Top Sellers
| 1 | -$160K | |
| 2 | -$72.1K | |
| 3 | -$59K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$53K |
| 5 |
B
Bailard
Foster City,
California
|
-$37.2K |